Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-04
DOI
10.1186/s13195-021-00892-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
- (2021) Johanna Michael et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4
- (2021) Shaowei Wang et al. Molecular Neurodegeneration
- The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
- (2020) Julia Marschallinger et al. Neurotherapeutics
- Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults
- (2020) Lynne Shinto et al. JOURNAL OF ALZHEIMERS DISEASE
- A possible effect of montelukast on neurological aging examined by the use of register data
- (2020) Bjørn Grinde et al. International Journal of Clinical Pharmacy
- An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer’s disease
- (2020) Anamitra Ghosh et al. Science Translational Medicine
- Improved Bioavailability of Montelukast through a Novel Oral Mucoadhesive Film in Humans and Mice
- (2020) Johanna Michael et al. Pharmaceutics
- Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
- (2019) Tamara Göbel et al. Frontiers in Pharmacology
- Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood–brain barrier
- (2019) Li Zhou et al. INFLAMMOPHARMACOLOGY
- Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set
- (2018) Lilah Besser et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment
- (2018) Di Yu et al. Translational Stroke Research
- Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified
- (2017) Bjørn Grinde et al. Immunity & Ageing
- The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy
- (2017) Alana N. Vagnozzi et al. Translational Psychiatry
- Results From the NACC Uniform Data Set Neuropsychological Battery Crosswalk Study
- (2016) Sarah E. Monsell et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Fitting Linear Mixed-Effects Models Usinglme4
- (2015) Douglas Bates et al. Journal of Statistical Software
- Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug
- (2015) Julia Marschallinger et al. Nature Communications
- MatchIt: Nonparametric Preprocessing for Parametric Causal Inference
- (2015) Daniel E. Ho et al. Journal of Statistical Software
- Montelukast rescues primary neurons against Aβ1–42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling
- (2014) Jin’e Lai et al. NEUROCHEMISTRY INTERNATIONAL
- Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice
- (2014) Jin'e Lai et al. NEUROPHARMACOLOGY
- The Neuropsychological Profile of Alzheimer Disease
- (2013) S. Weintraub et al. Cold Spring Harbor Perspectives in Medicine
- PPAR /RXR -Induced and CD36-Mediated Microglial Amyloid- Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice
- (2012) M. Yamanaka et al. JOURNAL OF NEUROSCIENCE
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- 5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo
- (2010) Jin Chu et al. ANNALS OF NEUROLOGY
- Leukotriene D4 induces gene expression in human monocytes through cysteinyl leukotriene type I receptor
- (2007) Grzegorz Woszczek et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now